Laura Erwin PhD

Dr. Laura Erwin holds a doctorate degree in pharmacology from LSU Health Sciences Center and received post-doctoral training from Harvard Medical School and Mclean Hospital. She has presented her work at conferences around the country, published on abuse liability and discussed scheduling issues and concerns with senators and representatives on Capitol Hill. Her extensive research background in preclinical pharmacology has aided her in assessing, communicating and managing the risks related to various types of products being developed (e.g., small molecules, biologics and devices).

In her current position as a Regulatory Scientist, she successfully helps companies create realistic clinical trial management plans and product development strategies that fulfill regulatory concerns, as well as fulfilling all regulatory concerns relating to FDA meeting preparation, IND submission, orphan drug designation and abuse liability assessment plans.